Vitality Watch

Dossier pubmed review 29-sep-2026
Narrative review or expert overview without new data

Personalized primary cardiovascular prevention: the convergences of risk scores, coronary calcium scoring and lipoprotein (a).

Key claim: Personalized primary cardiovascular prevention should integrate traditional risk scores with coronary artery calcium scoring, lipoprotein(a), and apolipoprotein B to guide statin therapy decisions.

Abstract

Despite major advances in the prevention and management of cardiovascular disease (CVD), it remains the leading cause of death worldwide, exceeding mortality attributable to COVID-19. Importantly, a substantial proportion of cardiovascular events are preventable, underscoring the critical importance of effective primary prevention. This brief review summarizes the latest European and American guideline recommendations, with a particular focus on cardiovascular risk assessment, the emerging roles of coronary artery calcium scoring, lipoprotein(a) and apolipoprotein B, and indications for statin therapy in the setting of primary cardiovascular prevention. In addition, it provides a practical, stepwise approach to assist clinicians in implementing individualized primary prevention strategies in routine practice.

Why this matters

Personalized primary cardiovascular prevention should integrate traditional risk scores with coronary artery calcium scoring, lipoprotein(a), and apolipoprotein B to guide statin therapy decisions.

Source

Link

Briefing card

Personalized primary cardiovascular prevention: the convergences of risk scores, coronary calcium scoring and lipoprotein (a).
Stage: review · pubmed · 29-sep-2026

Personalized primary cardiovascular prevention should integrate traditional risk scores with coronary artery calcium scoring, lipoprotein(a), and apolipoprotein B to guide statin therapy decisions.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.cpcardiol.2026.103469

build build 880 · 2bcef25 · 2026-11-18